alexa Abstract | Synthesis of 3-aryl amido/imido-methyl-4-hydroxy-phenyl-5'-phenyl-3'- oxazolyl acetophenone azines as potential antiviral agents

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


3-Aryl-amido/imido-methyl-4-hydroxy-phenyl-acetophenones (I) were prepared in excellent yields by condensing equilmolar amounts or p-hydroxy acetophenones and aryl-amido/imido-alcohols in the presence of conc. H2SO4. Reaction of (I) with semicarbazide, hydro-chloride in ethanol afforded 3-Aryl-amido/imido-methyl-4-hydroxyphenyl- acetophenone-semicarbazones (II) in the yields ranging from 60-70%. Reaction of (II) with acetophenone and iodine in glacial acetic acid afforded 3-Aryl-amido/imido-methyl-4-hydroxy-phenyl-5'-phenyl-3'-oxazolylacetophenone azines (III) in the yields ranging from 65-70%. Some of the compounds showed promising antiviral activity against three viruses viz., JEV, HSV-I and Influenza A viruses respectively. The present paper describes the synthesis and biological activity screening procedures.

To read the full article Peer-reviewed Article PDF image

Author(s): Seema Yadav


Thiosemicarbazones, Methisazone, biological screening, antiviral agents

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version